Springer

Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bureau, F.
Right arrow Articles by Lekeux, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bureau, F.
Right arrow Articles by Lekeux, P.
Related Collections
Right arrow Apoptosis
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 May 2002, Vol. 99, No. 10, pp. 3683-3691

IMMUNOBIOLOGY

Constitutive nuclear factor-kappa B activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins

Fabrice Bureau, Alain Vanderplasschen, Fabrice Jaspar, Frédéric Minner, Paul-Pierre Pastoret, Marie-Paule Merville, Vincent Bours, and Pierre Lekeux

From the Department of Veterinary Physiology, Department of Parasitic and Infectious Diseases, and Department of Medical Chemistry and Medical Oncology, University of Liège, Belgium.

Constitutive nuclear factor kappaB (NF-kappa B) activity protects quiescent mature immune cells from spontaneous apoptosis. Here, we examined whether NF-kappa B exerts its antiapoptotic function in these cells through the control of Bcl-2 family proteins. Specific pharmacologic inhibitors of NF-kappa B were used to achieve total NF-kappa B inactivation in quiescent human blood lymphocytes, granulocytes, and monocytes. NF-kappa B inhibition induced drastic lymphocyte and granulocyte apoptosis, but only moderate monocyte apoptosis. T- and B-cell apoptosis was slow and associated with a gradual down-regulation of the prosurvival Bcl-2 family proteins Bcl-xL and Bcl-2, respectively. By contrast, granulocyte apoptosis was fast and accompanied by a rapid cellular accumulation of Bcl-xS, the proapoptotic Bcl-x isoform that is generated from alternative splicing of the bcl-x pre-mRNA. Finally, antisense bcl-xL and bcl-2 knockdown in T and B cells, respectively, and induction of Bcl-xS expression in granulocytes through antisense oligonucleotide-mediated redirection of bcl-x pre-mRNA splicing were sufficient to induce significant apoptosis in these cells. Taken together, these results reveal that basal NF-kappa B activity preserves homeostasis of quiescent mature lymphocytes and granulocytes through regulation of distinct members of the Bcl-2 family. This study sheds light on the constitutive mechanisms by which NF-kappa B maintains defense integrity.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. Olivier, P. Close, E. Castermans, L. de Leval, S. Tabruyn, A. Chariot, M. Malaise, M.-P. Merville, V. Bours, and N. Franchimont
Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-{kappa}B Inhibition and Gene Expression Signature
Mol. Pharmacol., May 1, 2006; 69(5): 1615 - 1623.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Desmet, P. Gosset, B. Pajak, D. Cataldo, M. Bentires-Alj, P. Lekeux, and F. Bureau
Selective Blockade of NF-{kappa}B Activity in Airway Immune Cells Inhibits the Effector Phase of Experimental Asthma
J. Immunol., November 1, 2004; 173(9): 5766 - 5775.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. McCracken, E. Gallery, and J. M. Morris
Pregnancy-Specific Down-Regulation of NF-{kappa}B Expression in T Cells in Humans Is Essential for the Maintenance of the Cytokine Profile Required for Pregnancy Success
J. Immunol., April 1, 2004; 172(7): 4583 - 4591.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. DELHALLE, A. DUVOIX, M. SCHNEKENBURGER, F. MORCEAU, M. DICATO, and M. DIEDERICH
An Introduction to the Molecular Mechanisms of Apoptosis
Ann. N.Y. Acad. Sci., December 1, 2003; 1010(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. G. Brooks, P. A. Arlen, L. Gao, C. M. R. Kitchen, and J. A. Zack
Identification of T cell-signaling pathways that stimulate latent HIV in primary cells
PNAS, October 28, 2003; 100(22): 12955 - 12960.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. L. Barrans, P. A. S. Evans, S. J. M. O'Connor, S. J. Kendall, R. G. Owen, A. P. Haynes, G. J. Morgan, and A. S. Jack
The t(14;18) Is Associated with Germinal Center-derived Diffuse Large B-Cell Lymphoma and Is a Strong Predictor of Outcome
Clin. Cancer Res., June 1, 2003; 9(6): 2133 - 2139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Lim, H. Kim, and K. H. Kim
Expression of Ku70 and Ku80 Mediated by NF-kappa B and Cyclooxygenase-2 Is Related to Proliferation of Human Gastric Cancer Cells
J. Biol. Chem., November 22, 2002; 277(48): 46093 - 46100.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020